Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $4.49T
Decision snapshot: HRMY stock price vs NVDA: inconclusive — current versus $103.15 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NVDA's multiple
Implied fair value · at HRMY's multiple
Needs HRMY P/E.
Live quote
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HRMY FY 2025 (ended Dec 31, 2025) · NVDA FY 2026 (ended Jan 25, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 20.65x · EV / EBITDA 30.78x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
HARMONY BIOSCIENCES HOLDINGS, INC. · implied price per share
Bear
$42.25
Base
$49.71
Bull
$57.16
NVIDIA CORP · implied price per share
Bear
$47.37
Base
$55.73
Bull
$64.09
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.19x
0.06x
Net debt / EBITDA
Leverage against operating earnings
-2.20x
-0.25x
Cash and equivalents
Liquid reserves on the balance sheet
$775.34M
$45.23B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Jazz Pharmaceuticals plc
HRMY vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
HRMY vs SUPN
Intra-Cellular Therapies, Inc.
HRMY vs ITCI
ACADIA PHARMACEUTICALS INC
HRMY vs ACAD
Vanda Pharmaceuticals Inc.
HRMY vs VNDA
LivaNova PLC
HRMY vs LIVN
ADVANCED MICRO DEVICES INC
HRMY vs AMD
INTEL CORP
HRMY vs INTC
TEXAS INSTRUMENTS INC
HRMY vs TXN
Broadcom Inc.
HRMY vs AVGO
QUALCOMM INC/DE
HRMY vs QCOM
MICROCHIP TECHNOLOGY INC
HRMY vs MCHP
$163.66M
$9.47B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Edwyn research
Live quote
